BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
27.39
+1.28 (4.90%)
Dec 20, 2024, 4:00 PM EST - Market closed
BioLife Solutions Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for BioLife Solutions stock have an average target of 29, with a low estimate of 22 and a high estimate of 33. The average target predicts an increase of 5.88% from the current stock price of 27.39.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BLFS stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +9.53% | Dec 19, 2024 |
| Keybanc | Keybanc | Buy Maintains $30 → $33 | Buy | Maintains | $30 → $33 | +20.48% | Dec 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $29 → $27 | Strong Buy | Maintains | $29 → $27 | -1.42% | Nov 18, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $28 → $31 | Strong Buy | Maintains | $28 → $31 | +13.18% | Nov 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +16.83% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
110.22M
from 143.27M
Decreased by -23.07%
Revenue Next Year
100.17M
from 110.22M
Decreased by -9.12%
EPS This Year
-0.90
from -1.52
EPS Next Year
-0.23
from -0.90
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 121.1M | 112.9M | 157.4M | |||
| Avg | 110.2M | 100.2M | 133.9M | |||
| Low | 80.1M | 90.7M | 111.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -15.4% | 2.4% | 57.1% | |||
| Avg | -23.1% | -9.1% | 33.7% | |||
| Low | -44.1% | -17.8% | 10.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.83 | -0.08 | 0.34 |
| Avg | -0.90 | -0.23 | 0.13 |
| Low | -0.95 | -0.40 | -0.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.